FOR IMMEDIATE RELEASE
DC Wings of Hope Gala on February 24th to Benefit the Melanoma Research Foundation Washington, D.C., December 4, 2017 – DC Wings of Hope will be hosting our 8th Annual Gala on February 24, 2018, to benefit the Melanoma Research Foundation. Last year’s gala raised $250,000 to support medical research for finding effective treatments and a possible cure for melanoma.
This year’s gala will be held on Saturday, February 24, 2018 at the Ritz-Carlton, Tysons Corner, and will feature an amazing keynote speaker…Hall of Fame baseball player Mike Schmidt. Mike is often considered the greatest third baseman in baseball history. He spent 18 seasons in the Major Leagues racking up impressive stats and accolades, but today believes melanoma is the biggest game-changer of his life! He will be sharing his heartfelt story about his battle with melanoma and you don’t want to miss it! The gala will also include an evening of exquisite food and drinks, live music, silent/live auctions, and the opportunity to network with local business leaders.
Melanoma affects people at a younger age than do most other cancers. The average age of diagnosis is 50, meaning that this disease often impacts people who are at the prime of their life and the top of their career. It is also the leading cause of cancer for women in their upper 20’s, and the second leading cause of cancer for everyone aged 14 to 30. Because of this, melanoma is increasingly the topic of coverage in fashion magazines and in the cosmetic industry.
If you are interested in becoming a sponsor or donating to DC Wings of Hope, please visit our website at www.dcwingsofhope.com. For any questions, please contact Ashley Schubert at firstname.lastname@example.org or Julie Shuey at 571-267-2116.
The Melanoma Research Foundation is the largest non-profit in the country working exclusively in the area of melanoma. Over the past years, MRF has distributed millions of dollars to support basic science research focused on melanoma and its causes. This commitment to research is led by a Scientific Advisory Committee comprised of the leading melanoma researchers and clinicians in the world. Through a number of patient education and awareness activities, MRF impacts tens of thousands of people affected by melanoma each year.